Lyrica Not Effective for Lower Back Pain
A drug commonly prescribed to treat lower back pain caused by lumbar spinal stenosis is no more effective than a placebo, according to a small…
Pfizer
FDA Approves New Anti-Abuse Label for Embeda
The Food and Drug Administration has approved new labeling for Pfizer’s Embeda extended-release capsules, an opioid pain reliever that combines morphine with naltrexone to discourage…
FDA Gives ‘Priority Review’ to New Hydrocodone Painkiller
The race to be the first drug maker to get approval for a hydrocodone painkiller with an abuse-deterrent formula continues to heat up. Purdue Pharma…
Generic Celebrex Approved by FDA
New and cheaper generic versions of the pain reliever Celebrex will soon be on the market – potentially saving patients hundreds of dollars a month.…
Are Lyrica Commercials Realistic?
The commercials seem innocent enough. A mother who suffers from fibromylagia takes her young daughter to a carnival. Together they ride a Ferris wheel, play…
Neurontin ‘Snake Oil’ Lawsuit Upheld
The U.S. Supreme Court this week let stand a jury verdict that ordered Pfizer to pay $142 million to Kaiser Foundation Health for the illegal…
Brain Images Could Lead to ‘Personalized’ Pain Care
Brain imaging could someday be used to help develop new pain medicines and to personalize the treatment of chronic pain patients, according to a small…
Survey Finds Fibromyalgia Hurts Love Life
Forget the roses and the bottle of wine. When it comes to romance, fibromyalgia is a buzz killer. A new survey of fibromyalgia patients has…